Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open‐label, noninferiority study-Reference-Cited by-同舟云学术

Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open‐label, noninferiority study

Published:2019-10-19 Issue:1 Volume:20 Page:159-171
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Harland Robert C.¹^ORCID,Klintmalm Goran²,Jensik Stephen³,Yang Harold⁴,Bromberg Jonathan⁵^ORCID,Holman John⁶,Kumar Mysore S. A.⁶,Santos Vicki⁶,Larson Tami J.⁶,Wang Xuegong⁶

Affiliation:

1. Department of Surgery University of Arizona Tucson Arizona

2. Department of Transplantation Services Annette C. and Harold C. Simmons Transplant Institute Dallas Texas

3. Department of Surgery Rush University Chicago Illinois

4. Department of Surgery Pinnacle Health Transplant Associates Harrisburg Pennsylvania

5. Department of Surgery University of Maryland Baltimore Maryland

6. Astellas Pharma Global Development, Inc. Northbrook Illinois

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15591

Reference23 articles.

1. Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) Conference

2. Kidney Transplantation in the Context of Renal Replacement Therapy

3. Quality of Life After Kidney Transplantation: A Prospective Study

4. Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients

5. Impact of renal cadaveric transplantation on survival in end‐stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long‐term follow‐up;Schnuelle P;J Am Soc Nephrol,1998

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying protein–protein interactions: Latest and most popular approaches;Journal of Structural Biology;2024-12

2. Advancing immunosuppression in liver transplantation: A narrative review;Hepatobiliary & Pancreatic Diseases International;2024-10

3. Potential biomarkers of recurrent FSGS: a review;BMC Nephrology;2024-08-12

4. Iscalimab Combined With Transient Tesidolumab Prolongs Survival in Pig‐to‐Rhesus Monkey Renal Xenografts;Xenotransplantation;2024-07

5. Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumab;Biochemical and Biophysical Research Communications;2024-06